CLINICAL_TRIALS
trial_result
· 2015-10-15
Clinical Trial Update: Campath Maintenance in Chronic Lymphocytic Leukemia [NA]
Summary
This update reports that Campath (alemtuzumab) maintenance for chronic lymphocytic leukemia was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: Chronic Lymphocytic Leukemia | NA | Status: TERMINATED | Results posted: 2015-10-15